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diabetic chronic treatments (40% for both), and 27% were on insulin therapy.
The other antidiabetic medications, including glinide, glitazone, and acarbose
were rarely used (3%, 2%, and 5%, respectively). Mean baseline and post PCI
Cr levels were 102±52 and 122±81μmol/L. Rate of CIN was similar in
patients with or without metformin (21 vs 20%, respectively, p= 0.87).
Logistic regression for the risk of CIN taking into account classical risk fac-
tors showed no impact of chronic metformin therapy, even in stratified anal-
ysis in patients with chronic kidney disease. Hospital mortality was similar
between groups (7 vs 6%, respectively, p=0.69). Moreover, no case of lactic
acidosis was reported during the hospital stay.
Conclusion: In this multicentre study reflecting current clinical practice,
metformin treatment prior to primary PCI had no significant impact on CIN.
Larger studies are needed to confirm these findings.
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Aim: To compare cardiovascular (CV) outcomes after contemporary PCI
in patients with vs. without renal failure (RF) according to clinical presenta-
tion (ST-elevated myocardial infarction (STEMI), acute coronary syndrome
(ACS), and stable coronary artery disease (sCAD)).
Methods: Consecutive patients undergoing PCI with stent implantation
were prospectively included from 2007 to 2012. RF was defined by a CrCl
<60ml/min. The primary end-point was all cause-mortality. The secondary
endpoints were MACCE (cardiovascular death, myocardial infarction, stroke,
TLR), TLR (target lesion revascularization), and ARC definite/probable stent
thrombosis (ST) at one year.
Results: Among 5337 patients eligible, 1219 (23%) had PCI for STEMI,
1837 (34%) for ACS and 2281 (43%) for sCAD. There were 1441 (27%)
patients with RF. At one year, patients with RF had increased all-cause mor-
tality rates whatever the indication for PCI (Figure), with a 6 fold higher unad-
justed all-cause mortality rate in STEMI patients (41% vs. 7.5%) and a 3 fold
increase in ACS (19% vs. 6%) and sCAD (10% vs. 3%) patients compared to
noRF patients (p< 0.0001 for all comparisons). MACCE were also higher in
RF patients in each PCI indication (45% vs. 15% in STEMI, 23% vs. 14% in
ACS, and 14% vs. 9% in sCAD, p<0.05 for all). STEMI-noRF patients had
comparable mortality (p=0.209) and MACCE rates (p=0.658) than sCAD-RF
patients. TLR ranged from 5.5% to 7.4%, and definite/probable ST was <2.5%
without any difference in each PCI indication (p>0.05 for both). After multi-
variable analyses, RF was independently associated with an excess of death
with a more than doubled relative risk in STEMI compared to ACS and sCAD
patients (OR 5.3: CI 3.627-7.821 in STEMI vs. 2.1: CI 1.465-3.140 and 2.3:
CI: 1.507-3.469 in ACS and sCAD, respectively, p<0.0001).
Conclusion: RF is a stronger independent predictor of death after PCI in
patients with STEMI compared to patients with ACS and sCAD. CV prog-
nosis of sCAD-RF patients was found to be comparable to that of STEMI-
noRF patients.
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Purpose: Cardiac allograft vasculopathy (CAV) constitues a primary cause
of death after heart transplantation. Bare metal stents (BMS) have been used
for revascularization, but they are associated with a high-risk of restenosis.
Limited data have shown favourable results with percutaneous coronary inter-
ventions (PCI) using drug-eluting stents (DES) in this specific population. Our
study focuses on intra-stent restenosis (ISR) for DES in CAV, on new revas-
cularisation and mortality.
Methods: 97 consecutive heart transplant recipients with successful PCI
were treated with DES (n=106) and BMS (n=25). They were prospectively
followed-up at one year after PCI. An angiographic lesion-based analysis at
12-month follow-up and a patient-based survival analysis were performed.
Results: The lesion-based analysis within 12 months after PCI showed an
ISR rate with BMS of 12% and an ISR rate with DES of 3.8%. The target
lesion revascularization (TLR) was 8% for BMS and 2.8% for DES. However,
the target vessel revascularization was higher (16.5%) and the remote lesion
revascularization was 8.7%, indicating the rapid occurrence of new significant
lesions. Cardiac mortality at one year was 9.7% and extra- cardiac mortality
was 2.9%.
Conclusions: DES are associated with a low rate of TLR and can safely
be used in heart transplant recipients with coronary artery disease. However,
new significant lesions occurred at one year indicating a progression of CAV. 
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Backround: The hospital cardiac arrest (ACEH) represent the leading
cause of death worldwide. Despite improvements in their care, the prognosis
of these patients remains very pejorative, including those who have received
initial resuscitation success.The objective of this study was to evaluate the
influence of emergency coronary angiography (CAG) and primary percuta-
neous coronary intervention (PCI) on the outcome of patients survivors after
out-of-hospital cardiac arrest and living in ICU in the Auvergne region namely
coronary angiography.
Methods: During 18 months, a cohort of surviving patients admitted alive
in Aceh and resuscitation was incorporated in the CHU Gabriel Montpied. All
demographics, pre-hospital and hospital were analyzed. The multivariate anal-
ysis of prognostic factors in this cohort used mainly the Cox model.
Results: 54 consecutive patients with out-of-hospital cardiac arrest survi-
vors underwent systematic emergency coronary angiography. Most (65%)
OHCA survivors had angiographic coronary artery disease: occlusion in
23 patients (43%) and significant stenosis in 12 patients (22%). Angioplasty
was attempted in 20 patients and was technically successful in 18. Chest pain
and the presence of ST-segment elevation were poor predictors of acute coro-
nary-artery occlusion. Hospital survival was 48%. By multivariable analysis,
use of PCI was an independent factor of survival (p=0.006). 
Conclusion: Acute coronary-artery occlusion is frequent in survivors of
out-of-hospital cardiac arrest and is predicted poorly by clinical and electro-
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